Effects of motive-oriented therapeutic relationship in a ten-session general psychiatric treatment of borderline personality disorder: a randomized controlled trial.

Détails

Ressource 1Télécharger: 24752034.pdf (435.34 [Ko])
Etat: Public
Version: Author's accepted manuscript
ID Serval
serval:BIB_01F264B2831C
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Effects of motive-oriented therapeutic relationship in a ten-session general psychiatric treatment of borderline personality disorder: a randomized controlled trial.
Périodique
Psychotherapy and Psychosomatics
Auteur⸱e⸱s
Kramer U., Kolly S., Berthoud L., Keller S., Preisig M., Caspar F., Berger T., de Roten Y., Marquet P., Despland J.N.
ISSN
1423-0348 (Electronic)
ISSN-L
0033-3190
Statut éditorial
Publié
Date de publication
2014
Peer-reviewed
Oui
Volume
83
Numéro
3
Pages
176-186
Langue
anglais
Notes
Publication types: Journal ArticlePublication Status: ppublish
Résumé
Background: Motive-oriented therapeutic relationship (MOTR) was postulated to be a particularly helpful therapeutic ingredient in the early treatment phase of patients with personality disorders, in particular with borderline personality disorder (BPD). The present randomized controlled study using an add-on design is the first study to test this assumption in a 10-session general psychiatric treatment with patients presenting with BPD on symptom reduction and therapeutic alliance. Methods: A total of 85 patients were randomized. They were either allocated to a manual-based short variant of the general psychiatric management (GPM) treatment (in 10 sessions) or to the same treatment where MOTR was deliberately added to the treatment. Treatment attrition and integrity analyses yielded satisfactory results. Results: The results of the intent-to-treat analyses suggested a global efficacy of MOTR, in the sense of an additional reduction of general problems, i.e. symptoms, interpersonal and social problems (F1, 73 = 7.25, p < 0.05). However, they also showed that MOTR did not yield an additional reduction of specific borderline symptoms. It was also shown that a stronger therapeutic alliance, as assessed by the therapist, developed in MOTR treatments compared to GPM (Z55 = 0.99, p < 0.04). Conclusions: These results suggest that adding MOTR to psychiatric and psychotherapeutic treatments of BPD is promising. Moreover, the findings shed additional light on the perspective of shortening treatments for patients presenting with BPD. © 2014 S. Karger AG, Basel.
Pubmed
Web of science
Open Access
Oui
Création de la notice
09/05/2014 14:26
Dernière modification de la notice
14/06/2021 13:31
Données d'usage